• Most Popular
  • Most Shared

Reuters Showcase

Bleak Econ Outlook

Bleak Econ Outlook

More analysts cut India's GDP forecasts.  Full Article 

Rajat Gupta Case

Rajat Gupta Case

Email, wiretaps, at trial link Rajat Gupta to Rajaratnam.  Full Article 

Facebook IPO Fallout

Facebook IPO Fallout

Facebook fallout: Silicon Valley won't snub Morgan Stanley.  Full Article 

Grexit?

Grexit?

Eurozone governments ponder Greek exit contingency.  Full Article 

Diesel Prices

Diesel Prices

Blog: It's time India bites the diesel bullet.  Full Article 

Buy, Sell or Hold?

Buy, Sell or Hold?

Stock recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

REFILE-UPDATE 1-Ranbaxy hires Giuliani to help it with FDA ban

Related Topics

Stocks

   

Thu Sep 18, 2008 9:11am IST

(Refiles to show in final paragraph that Ranbaxy shares trade on Mumbai exchange, not Bangalore)

NEW YORK, Sept 17 (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd (RANB.BO) has hired former New York City Mayor Rudolph Giuliani as an adviser, the company said on Wednesday, one day after regulators banned the U.S. sale of dozens of its drugs.

The U.S. Food and Drug Administration said on Tuesday that it would block more than 30 generic drugs from entering the United States because of ongoing procedural violations in manufacturing at Ranbaxy's Dewas and Paonta Sahib plants in India.

"Ranbaxy is committed to a swift resolution to address these issues and to continuing to supply the global marketplace with safe and effective pharmaceuticals," the company said in a a statement.

The agency has said it would not approve any further medications made at the two plants or lift its so-called "import alert" until the problems were fixed. It issued an earlier warning in 2006.

Ranbaxy, which has agreed to a takeover by Japan's Daiichi Sankyo Co Ltd (4568.T), said it had retained the services of Giuliani and his consulting firm Giuliani Partners for advice and a review of compliance issues related to the agency's action. Giuliani had sought the Republican presidential nomination until dropping out in January.

Shares of Ranbaxy earlier fell 6.6 percent on on Wednesday on the Mumbai exchange. (Reporting by Sinead Carew in New York and Susan Heavey in Washington; Editing by Gary Hill)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.